Interestingly, our lab recently showed that NRAS/BRAF-driven melanoma, pancreatic, or colorectal cancer cell lines increase a metabolic process, called autophagy, upon MEK1/2 inhibition, a process we will discuss in the following section [77]. The gene discussed is BRAF; the disease is melanoma.